This US-based endocrinologist discusses the disease burden of obesity, the current treatment paradigm for obesity including the use of older drugs and newer therapeutics, as well as drugs of interest in the development pipeline and the future of obesity drug treatment.

This interview was conducted on 10 June, 2025.

If you are a Datamonitor Healthcare client, you may access the interview from our KOL Insight channel.

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal.

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900.